I think it will churn around the 20c mark. Hopefully will then continue to regain lost ground and run up beyond 40c. I really hope the company gets the word out like MT was so capable of doing. Now is the time to strike while the iron is hot and gather momentum. Won't have another opportunity for massive news like this again for some time.
- Forums
- ASX - By Stock
- Ann: PharmAust receives Orphan Drug Designation for monepantel
I think it will churn around the 20c mark. Hopefully will then...
Featured News
Add NUZ (ASX) to my watchlist
(20min delay)
|
|||||
Last
20.0¢ |
Change
0.010(5.26%) |
Mkt cap ! $98.34M |
Open | High | Low | Value | Volume |
20.0¢ | 20.5¢ | 19.5¢ | $86.20K | 429.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 67508 | 19.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
20.0¢ | 36444 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 47508 | 0.195 |
6 | 238826 | 0.190 |
12 | 723520 | 0.185 |
6 | 377800 | 0.180 |
5 | 151797 | 0.175 |
Price($) | Vol. | No. |
---|---|---|
0.200 | 36444 | 3 |
0.205 | 21529 | 1 |
0.210 | 107676 | 2 |
0.215 | 154400 | 2 |
0.220 | 190000 | 3 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
NUZ (ASX) Chart |
The Watchlist
BTH
BIGTINCAN HOLDINGS LIMITED
David Keane, Co-Founder & CEO
David Keane
Co-Founder & CEO
Previous Video
Next Video
SPONSORED BY The Market Online